Publication Number

100-3

Manual Section Number

20.22

Version Number

1

Effective Date of this Version

This is a longstanding national coverage determination. The effective date of this version has not been posted.

Benefit Category

Physicians' Services

Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

Indications and Limitations of Coverage

The use of EDTA as a chelating agent to treat atherosclerosis, arteriosclerosis, calcinosis, or similar generalized condition not listed by the FDA as an approved use is not covered. Any such use of EDTA is considered experimental. 

Cross Reference

See §20.21 of the NCD Manual.

 Add to basket  |   Email this to a friend  |   New Search

Page Last Modified: 4/23/2009 7:26:58 AM

Help with File Formats and Plug-Ins

Submit Feedback